FDA-approved indications for the use of oral hypoglycemic drugs primarily focus on type 2 diabetes mellitus. Non-FDA approved indications of oral hypoglycemic drugs, such as metformin, are for the prevention of type 2 diabetes mellitus, treatment of gestational diabetes mellitus, treatment of polycystic ovary syndrome (PCOS) with menstrual irregularities, and prevention of ovarian
Other oral hypoglycemic drugs are reviewed separately. (See Metformin in the treatment of adults with type 2 diabetes mellitus and Thiazolidinediones in the treatment of type 2 diabetes mellitus and Sulfonylureas and meglitinides in the treatment of type 2 diabetes mellitus .)
new medicinal products for the treatment of diabetes mellitus. It also Keywords: Diabetes, drug evaluation, clinical development, treatment
Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis. Not for patients with preexisting severe GI disease. PEDIATRIC. Diabetes Mellitus Type 2.
Pioglitazone: Drug information Diabetes mellitus, type 2, treatment. Diabetes mellitus, type 2, treatment: Insulin resistance/prediabetes, secondary
FDA-approved indications for the use of oral hypoglycemic drugs primarily focus on type 2 diabetes mellitus. Non-FDA approved indications of oral hypoglycemic drugs, such as metformin, are for the prevention of type 2 diabetes mellitus, treatment of gestational diabetes mellitus, treatment of polycystic ovary syndrome (PCOS) with menstrual irregularities, and
Diabetes mellitus, type 2, treatment. Diabetes mellitus, type 2, treatment: Nonalcoholic steatohepatitis. Nonalcoholic steatohepatitis (off-label use):.
Drugs for treatment of Diabetes Mellitus. Naser Tadvi. 28.5K
Sulfonylureas ; Gliquidone, A sulfonylurea drug used in the management of diabetes mellitus type 2. ; Glisoxepide, For the treatment of diabetes mellitus type 2.
Comments